Skip to content
value.today

Zbiotics Co

Total raised
$28 M
2 rounds on record
Latest round
$22 M
Mar 2024
First round on record
Mar 2020
Today
Private
No later event on record

Funding rounds

2 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Zbiotics Co
MonthRaisedRaiseSizeInvestorsSoldFiling
Mar 2024$22 MNo. 2$10 to $50 million

Zbiotics Co: Raise no. 2, Mar 2024

Investors in this round

68 investors had bought by the notice of Apr 9, 2024: 68 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$22 M of $22 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Stephen Donald Lamb · Executive Officer, Director
  • Zachary Donald Abbott · Executive Officer, Director
  • Adam Donald Ramada · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “Includes $8,423,351.35 in value of cancelled convertible securities, and includes $1,999,999.92 in value of equity securities issued in exchange for existing capital stock of the Issuer.”

Signed by Zachary Donald Abbott, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 9, 2024. Read the notice at the SEC.

equitySEC
Mar 2020$6 MNo. 1$2 to $10 million

Zbiotics Co: Raise no. 1, Mar 2020

Investors in this round

38 investors had bought by the notice of Mar 24, 2020: 38 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$6 M of $6 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and finders' fees and payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Stephen Lamb · Executive Officer, Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Nicole Hatcher, Attorney-in-Fact. Source: SEC Form D, newest notice filed Mar 24, 2020. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Zbiotics Co chose not to state its revenue in its newest notice of a funding round (Apr 2024).

    SEC Form D · Apr 2024

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Apr 2024

That is all the official record says: Zbiotics Co has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Zbiotics Co is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 2 rounds above had up to 68 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Zbiotics Co
NameRoleNamed in
Stephen Donald LambExecutive officerApr 2024
Zachary Donald AbbottExecutive officerApr 2024
Stephen LambExecutive officerMar 2020
Adam Donald RamadaDirectorApr 2024
Stephen Donald LambDirectorApr 2024
Zachary Donald AbbottDirectorApr 2024
Stephen LambDirectorMar 2020